sellModerate
Iqbal J Hussain sold $1.0M of CNTA
Chief Legal Officer at Centessa Pharmaceuticals plc. 39,961 shares at an average of $25.15, traded Jan 30, 2026, filed Feb 3, 2026.
Warning score
50Value
$1.0M
39,961 shares
Holdings after
57,645
-38% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +25Trade size$1.0M at market
- +10Share of holdings soldSold 38% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001470831-26-000092, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 30, 2026 | SOpen-market sale Ordinary Shares | -1,010 | $25.01 | $25k | 104,376 | Feb 3, 2026 |
| Feb 1, 2026 | FTax withholding Ordinary Shares | -7,780 | $24.57 | $191k | 96,596 | Feb 3, 2026 |
| Feb 2, 2026 | SOpen-market sale Ordinary Shares | -38,951 | $25.15 | $980k | 57,645 | Feb 3, 2026 |
| Feb 2, 2026 | AGrant or award Ordinary Shares | +40,000 | $0.00 | $0 | 97,645 | Feb 3, 2026 |
| Feb 2, 2026 | AGrant or award Ordinary Shares | +20,000 | $0.00 | $0 | 117,645 | Feb 3, 2026 |
| Feb 2, 2026 | AGrant or award Share Option (right to buy)derivative | +160,000 | $0.00 | $0 | 160,000 | Feb 3, 2026 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $1.2M 41,076 shares | -40% | |
| 19Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $720k 23,998 shares | -27% | |
| 33Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $2.1M 74,811 shares | -59% | |
| 33Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $3.2M 120,029 shares | -66% | |
| 33Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $3.2M 120,029 shares | -66% | |
| 48Moderate | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $1.9M 73,196 shares | -53% | |
| 14Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $288k 10,000 shares | -5% | |
| 0Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $300k 10,000 shares | -5% | |
| 18Weak | Centessa Pharmaceuticals plc | Tia L Bush Chief Technology & Quality Ofc | $1.1M 40,000 shares | -25% | |
| 0Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $166k 6,000 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.